Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score

被引:32
作者
Huo, TI [1 ]
Lin, HC
Lee, FY
Hou, MC
Lee, PC
Wu, JC
Chang, FY
Lee, SD
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
关键词
esophageal varices; hepatic encephalopathy; liver cirrhosis; liver transplantation; MELD; spontaneous bacterial peritonitis;
D O I
10.1111/j.1478-3231.2005.01190.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The model for end-stage liver disease (MELD) is used to prioritize cirrhotic patients awaiting liver transplantation. Many cirrhosis-related complications are indications for transplantation but are not included in MELD. This study investigated the impact of these complications on survival and association with MELD. Methods: The mortality risk of cirrhosis-related complications, including bleeding esophageal varices. spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome and hepatic decompensation, was analyzed using a time-dependent Cox regression model in 227 cirrhotic patients. Results: A total of 281 episodes of complications occurred in 142 (63%) patients. Patients who died had a significantly higher baseline MELD score compared with those who survived (14.5 +/- 4.5 vs 12.8 +/- 3.9, P=0.004). There was no significant difference in the MELD score between patients with and without the occurrence of complications (13.6 +/- 4.3 vs 12.9 +/- 4.0, P=0.093). Patients with a higher baseline MELD score tended to develop early complications (rho=-0.598, P<0.001). Using the Cox regression model, the risk ratio of mortality was 4.9 (95% confidence interval: 3.9-6.3, P<0.0001) for each additional episode of complication. Conclusions: The mortality risk increases as the number of complication episodes increases. While patients with repeated complications have a poor outcome, they do not necessarily have a higher baseline MELD score and could be down-staged in the MELD era.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 31 条
[21]   Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis:: a consensus document [J].
Rimola, A ;
García-Tsao, G ;
Navasa, M ;
Piddock, LJV ;
Planas, R ;
Bernard, B ;
Inadomi, JM .
JOURNAL OF HEPATOLOGY, 2000, 32 (01) :142-153
[22]   Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease [J].
Said, A ;
Williams, J ;
Holden, J ;
Remington, P ;
Gangnon, R ;
Musat, A ;
Lucey, MR .
JOURNAL OF HEPATOLOGY, 2004, 40 (06) :897-903
[23]   MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt [J].
Salerno, F ;
Merli, M ;
Cazzaniga, M ;
Valeriano, V ;
Rossi, P ;
Lovaria, A ;
Meregaglia, D ;
Nicolini, A ;
Lubatti, L ;
Riggio, O .
JOURNAL OF HEPATOLOGY, 2002, 36 (04) :494-500
[24]   Comparison of MELD, Child-Pugh, and emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting [J].
Schepke, M ;
Roth, F ;
Fimmers, R ;
Brensing, KA ;
Sudhop, T ;
Schild, HH ;
Sauerbruch, T .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05) :1167-1174
[25]   MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis [J].
Srikureja, W ;
Kyulo, NL ;
Runyon, BA ;
Hu, KQ .
JOURNAL OF HEPATOLOGY, 2005, 42 (05) :700-706
[26]   Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment [J].
Testa, R ;
Testa, E ;
Giannini, E ;
Botta, F ;
Malfatti, F ;
Chiarbonello, B ;
Fumagalli, A ;
Polegato, S ;
Podesta, E ;
Romagnoli, P ;
Risso, D ;
Cittadini, G ;
De Caro, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (12) :1563-1569
[27]  
*US DEP HHS, 2000, ANN REP US SCI REG O
[28]   Liver transplantation in the era of model for end-stage liver disease [J].
Wang, VS ;
Saab, S .
LIVER INTERNATIONAL, 2004, 24 (01) :1-8
[29]   Model for End-Stage Liver Disease (MELD) and allocation of donor livers [J].
Wiesner, R ;
Edwards, E ;
Freeman, R ;
Harper, A ;
Kim, R ;
Kamath, P ;
Kremers, W ;
Lake, J ;
Howard, T ;
Merion, RM ;
Wolfe, RA ;
Krom, R .
GASTROENTEROLOGY, 2003, 124 (01) :91-96
[30]   MELD and PELD: Application of survival models to liver allocation [J].
Wiesner, RH ;
McDiarmid, SV ;
Kamath, PS ;
Edwards, EB ;
Malinchoc, M ;
Kremers, WK ;
Krom, RAF ;
Kim, WR .
LIVER TRANSPLANTATION, 2001, 7 (07) :567-580